<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01740180</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2012/GT</org_study_id>
    <secondary_id>Taieb Cohorte CLIPPERS</secondary_id>
    <nct_id>NCT01740180</nct_id>
  </id_info>
  <brief_title>Cortico-saving Treatments Proposed for CLIPPERS: a First Cohort</brief_title>
  <official_title>Cortico-saving Treatments Proposed for CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Responsive to Steroids): a First Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to collect information about how CLIPPERS patients are
      currently being treated in France.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study. Data will be prospectively collected, starting with a
      detailed baseline description of disease and treatment status, followed by updates everything
      six months for the next three years.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No recruitment
  </why_stopped>
  <start_date type="Actual">March 25, 2015</start_date>
  <completion_date type="Actual">March 25, 2016</completion_date>
  <primary_completion_date type="Actual">March 25, 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Presence/absence of cortico-sparing treatments</measure>
    <time_frame>baseline to 3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>Baseline (day 0)</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>Baseline (day 0)</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>Baseline (Day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>6 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>12 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>18 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>21 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>24 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>30 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of allergies</measure>
    <time_frame>36 months</time_frame>
    <description>+ description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>21 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete description of all treatments being taken</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>6 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>12 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>18 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>21 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>24 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>30 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLIPPERS relapse severity</measure>
    <time_frame>36 months</time_frame>
    <description>The rhythm and severity of relapses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>21 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free interval rhythm</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>21 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight (kg)</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>21 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of vascular risk factors</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>21 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relapses in the past 6 months while taking &gt;= 20 mg/ day corticoids</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Family history of auto-immune disease</measure>
    <time_frame>Baseline</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Height (cm)</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3</enrollment>
  <condition>CLIPPERS</condition>
  <arm_group>
    <arm_group_label>CLIPPERS patients</arm_group_label>
    <description>The population concerned by this study consists of patients diagnosed according to CLIPPERS criteria (see inclusion and exclusion criteria).
Intervention: Data entry</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data entry</intervention_name>
    <description>This cohort describes the basic information about the patients (age, sex, weight, height, background) as well as acts required, treatment and results of imaging studies.
These data are extracted from patient records by each participating center and collected in an e-CRF.</description>
    <arm_group_label>CLIPPERS patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The population concerned by this study consists of patients diagnosed according to CLIPPERS
        criteria (see inclusion and exclusion criteria).

        Patients will be recruited from referral centers throughout France. We also intend to
        communicate with all multiple sclerosis networks (French League against Multiple Sclerosis)
        to facilitate the detection of new cases.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient correctly informed about the study

          -  Symptoms and/or clinical signs indicating that the brain stem is affected

          -  MRI shows punctate gadolinium highlights and/or curvilinear bridge and/or middle
             cerebellar peduncles

          -  Clinical and radiological cortico sensitivity

          -  If a cerebral biopsy has been performed, presence of a lymphocytic, histiocytic or
             lympho-hysticytic infiltrate

        Exclusion Criteria:

          -  symptoms and/or clinical signs indicating impairment other than the central nervous
             system

          -  Cortical impairment present on MRI, microbleeds, stenosis on magnetic resonance
             angiography, or pacchymeningitis

          -  Presence of other diseases that could explain such clinical and radiological signs
             (see inclusion criteria)

          -  If a cerebral biopsy has been performed, presence of signs of malignancy (eg, clonal
             proliferation, cellular atypia), vasculitis, granuloma, or demyelination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume Taieb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Bordeaux - Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Dax - Côte d'Argent</name>
      <address>
        <city>Dax</city>
        <zip>40100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges - Hôpital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - Hôpital La Timone Adultes</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Saint-Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen - Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Strasbourg - Hôpital Civil</name>
      <address>
        <city>Strasbourg Cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Toulouse - Hôpital de Rangueil</name>
      <address>
        <city>Toulouse Cedex 9</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Toulouse - Hôpital Purpan</name>
      <address>
        <city>Toulouse Cedex 9</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Tours - Hôpital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2012</study_first_submitted>
  <study_first_submitted_qc>November 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

